Performance Testing for Dry Powder Inhaler Products: Towards Clinical Relevance

Performance Testing for Dry Powder Inhaler Products: Towards Clinical Relevance

It is well established that the critical performance metrics for aerosol products are aerodynamic particle size distribution (APSD) and delivered dose uniformity (DDU). In broad terms, these performance characteristics dictate the efficiency and reproducibility with which an aerosol is administered...

Full description

Bibliographic Details
Main Authors: Sara E. Maloney, Jeffrey B. Mecham, Anthony J. Hickey
Format: Article
Language:English
Published: Hosokawa Powder Technology Foundation 2022-09-01
Series:KONA Powder and Particle Journal
Subjects:
dry powder inhaler
therapeutic aerosol
aerodynamic particle size distribution
cascade impaction
in vitro/in vivo correlation
bioequivalence
Online Access:https://www.jstage.jst.go.jp/article/kona/40/0/40_2023013/_html/-char/en

Internet

https://www.jstage.jst.go.jp/article/kona/40/0/40_2023013/_html/-char/en

Similar Items